These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18712728)

  • 1. ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts.
    Hu ZY; Zhu XF; Zhong ZD; Sun J; Wang J; Yang D; Zeng YX
    Int J Cancer; 2008 Nov; 123(10):2418-29. PubMed ID: 18712728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoG2 inhibits antiapoptotic Bcl-2 family proteins and induces mitochondria-dependent apoptosis in human lymphoma U937 cells.
    Sun J; Li ZM; Hu ZY; Lin XB; Zhou NN; Xian LJ; Yang DJ; Jiang WQ
    Anticancer Drugs; 2008 Nov; 19(10):967-74. PubMed ID: 18827561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apogossypolone, a small-molecule inhibitor of Bcl-2, induces radiosensitization of nasopharyngeal carcinoma cells by stimulating autophagy.
    He JH; Liao XL; Wang W; Li DD; Chen WD; Deng R; Yang D; Han ZP; Jiang JW; Zhu XF
    Int J Oncol; 2014 Sep; 45(3):1099-108. PubMed ID: 24919770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.
    Mi JX; Wang GF; Wang HB; Sun XQ; Ni XY; Zhang XW; Tang JM; Yang DJ
    Acta Pharmacol Sin; 2008 Dec; 29(12):1467-77. PubMed ID: 19026166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway.
    Hu ZY; Sun J; Zhu XF; Yang D; Zeng YX
    J Transl Med; 2009 Aug; 7():74. PubMed ID: 19698176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Bcl-2 antisense oligodeoxynucleotide in combination with cisplatin cures EBV+ nasopharyngeal carcinoma xenografts in SCID mice.
    Lacy J; Loomis R; Grill S; Srimatkandada P; Carbone R; Cheng YC
    Int J Cancer; 2006 Jul; 119(2):309-16. PubMed ID: 16477627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
    Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen species.
    Hu ZY; Wang J; Cheng G; Zhu XF; Huang P; Yang D; Zeng YX
    Chin J Cancer; 2011 Jan; 30(1):41-53. PubMed ID: 21192843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression.
    Li-juan B; Bing L; Zhi L; Yang L; Ying-jie L
    Pathol Res Pract; 2009; 205(12):828-37. PubMed ID: 19625133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells.
    Xin J; Zhan YH; Xia LM; Zhu HW; Nie YZ; Liang JM; Tian J
    Biomed Pharmacother; 2013 Feb; 67(1):88-95. PubMed ID: 23201009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivo.
    Sun Y; Wu J; Aboukameel A; Banerjee S; Arnold AA; Chen J; Nikolovska-Coleska Z; Lin Y; Ling X; Yang D; Wang S; Al-Katib A; Mohammad RM
    Cancer Biol Ther; 2008 Sep; 7(9):1418-26. PubMed ID: 18769131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apogossypolone induces autophagy and apoptosis in breast cancer MCF-7 cells in vitro and in vivo.
    Niu X; Li S; Wei F; Huang J; Wu G; Xu L; Xu D; Wang S
    Breast Cancer; 2014 Mar; 21(2):223-30. PubMed ID: 22711315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoG2 inhibits the antiapoptotic protein, Mcl‑1, and induces mitochondria‑dependent apoptosis in human colorectal cancer cells.
    Li T; Yuan G; Zhang L; Ye L; Li S; Fan Y; Sun J
    Mol Med Rep; 2015 Nov; 12(5):6976-84. PubMed ID: 26352605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apogossypolone induces apoptosis and autophagy in nasopharyngeal carcinoma cells in an
    Zheng R; Chen K; Zhang Y; Huang J; Shi F; Wu G; Wang S
    Oncol Lett; 2017 Jul; 14(1):751-757. PubMed ID: 28693230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
    Lu Y; Huang H; Yang H; Chen D; Wu S; Jiang Z; Wang R
    Cell Cycle; 2017 Jul; 16(14):1376-1383. PubMed ID: 28696828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical studies of apogossypolone, a novel pan inhibitor of bcl-2 and mcl-1, synergistically potentiates cytotoxic effect of gemcitabine in pancreatic cancer cells.
    Banerjee S; Choi M; Aboukameel A; Wang Z; Mohammad M; Chen J; Yang D; Sarkar FH; Mohammad RM
    Pancreas; 2010 Apr; 39(3):323-31. PubMed ID: 19823097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells.
    Low SY; Tan BS; Choo HL; Tiong KH; Khoo AS; Leong CO
    Cancer Lett; 2012 Jan; 314(2):166-75. PubMed ID: 22033244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts.
    Cao LH; Li HT; Lin WQ; Tan HY; Xie L; Zhong ZJ; Zhou JH
    Sci Rep; 2016 Jan; 6():18706. PubMed ID: 26729257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo.
    Zhao YY; Tian Y; Zhang J; Xu F; Yang YP; Huang Y; Zhao HY; Zhang JW; Xue C; Lam MH; Yan L; Hu ZH; Dinglin XX; Zhang L
    Drug Des Devel Ther; 2014; 8():1827-37. PubMed ID: 25336925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo.
    Zhang X; Hu X; Mu S; Zhan Y; An Q; Liu Z; Huang X
    Mol Med Rep; 2014 Sep; 10(3):1184-94. PubMed ID: 25060748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.